Endo Pharmaceuticals Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 1,085.6 | 909.7 | 820.2 |
| Cost of Goods Sold | 217.4 | 201.4 | 186.4 |
| Gross Profit | 868.2 | 708.2 | 633.8 |
| Gross Profit Margin | 80.0% | 77.9% | 77.3% |
| SG&A Expense | 534.7 | 481.1 | 305.9 |
| Depreciation & Amortization | 16.3 | 16.6 | 14.6 |
| Operating Income | 317.2 | 210.5 | 313.3 |
| Operating Margin | 29.2% | 23.1% | 38.2% |
| Nonoperating Income | 36.1 | 24.5 | 12.7 |
| Nonoperating Expenses | 0.1 | 1.3 | 1.7 |
| Income Before Taxes | 353.3 | 233.7 | 324.2 |
| Income Taxes | 125.8 | 95.9 | 121.9 |
| Net Income After Taxes | 227.4 | 137.8 | 202.3 |
| Continuing Operations | 227.4 | 137.8 | 202.3 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 227.4 | 137.8 | 202.3 |
| Total Net Income | 227.4 | 137.8 | 202.3 |
| Net Profit Margin | 21.0% | 15.2% | 24.7% |
| Diluted EPS from Total Net Income ($) | 1.69 | 1.03 | 1.52 |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
